Regencell Bioscience Holdings (RGC) Operating Leases (2022 - 2025)
Regencell Bioscience Holdings' (RGC) quarterly Operating Leases came in at $128178.0 in Q4 2025, down 44.66% on a QoQ basis from $231635.0 in Q2 2025.
Regencell Bioscience Holdings (RGC) Operating Leases (2022 - 2025) Analysis & Trends
Regencell Bioscience Holdings (RGC) has 4 years of Operating Leases data on file, last reported at $128178.0 in Q4 2025.
- Quarterly Operating Leases changed N/A year-over-year to $128178.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $128178.0 (changed N/A YoY) and the FY2025 annual result came in at $231635.0, up 793.17% from the prior year.
- Operating Leases slipped to $128178.0 in Q4 2025, from $231635.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $771255.0 in Q2 2022 to a low of $25406.0 in Q2 2023.
- A 4-year average of $236481.6 and a median of $128178.0 in 2025 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases sank 96.71% — and 2025, when it jumped 793.17%.
- Tracing RGC's Operating Leases over 4 years: stood at $771255.0 in 2022, then slumped by 96.71% to $25406.0 in 2023, then increased by 2.08% to $25934.0 in 2024, then jumped by 394.25% to $128178.0 in 2025.
- The last three Operating Leases figures came in at $128178.0 (Q4 2025), $231635.0 (Q2 2025), and $25934.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Regencell Bioscience Holdings | 2.67 Bn | 2.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 128,178.00 |
| Jun 30, 2025 | 231,635.00 |
| Jun 30, 2024 | 25,934.00 |
| Jun 30, 2023 | 25,406.00 |
| Jun 30, 2022 | 771,255.00 |